No Data
No Data
No Data
No Data
No Data
Institutional Investors of Neumora Therapeutics, Inc. (NASDAQ:NMRA) Must Be Disappointed After Last Week's 14% Drop
Key Insights Given the large stake in the stock by institutions, Neumora Therapeutics' stock price might be vulnerable to their trading decisions 52% of the business is held by the top 4 shareholder
Simply Wall StApr 26 06:43 ET
We're Hopeful That Neumora Therapeutics (NASDAQ:NMRA) Will Use Its Cash Wisely
Yahoo FinanceApr 24 08:14 ET
Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN), Innate Pharma SA (OtherIPHYF) and Neumora Therapeutics, Inc. (NMRA)
TipRanksApr 17 04:10 ET
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) fell sharply during Monday's session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic d
BenzingaApr 15 14:11 ET
Why Is Neurology Focused-Neumora Therapeutics Shares Trading Lower On Monday?
Neumora Therapeutics Inc (NASDAQ:NMRA) shares plummeted after the FDA placed a clinical hold on the company's Phase 1 trial of NMRA-266.NMRA-266 is a positive allosteric modulator (PAM) of the M4 musc
BenzingaApr 15 10:17 ET
Express News | Neumora Therapeutics Shares Down 17% After US FDA Puts Schizophrenia Drug Trial on Hold
Moomoo 24/7Apr 15 09:32 ET
102547332 : how about EZGO?
101695476 : what is your view on CheChe grp
PYUN970IHaveChosen : ! McHTp
Mcsnacks H TupackOP 102547332: Ezgo is adding warrants before they reverse split
Mcsnacks H TupackOP 101695476: CCG will have to fall to about 12.10 before it recovers
No Data
No Data